Scott W Hiebert Selected Research

Scott W Hiebert Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 07/2002
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 07/2002
8	Leukemia 07/2013 - 07/2002
8	Genetic Translocation (Chromosomal Translocation) 12/2009 - 03/2003
6	Carcinogenesis 01/2022 - 04/2008
4	Colitis 01/2022 - 08/2006
4	Genomic Instability 07/2015 - 11/2010
3	Carcinoma (Carcinomatosis) 01/2019 - 01/2012
3	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2015 - 01/2013
2	Breast Neoplasms (Breast Cancer) 11/2020 - 02/2008
2	Inflammation (Inflammations) 01/2019 - 10/2013
2	Lymphoma (Lymphomas) 01/2017 - 07/2013
2	Ulcerative Colitis 10/2013 - 08/2006
1	Triple Negative Breast Neoplasms 11/2020
1	Nervous System Neoplasms (Neoplasms, Nervous System) 11/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 08/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2017
1	Hematologic Neoplasms (Hematological Malignancy) 02/2016
1	Ovarian Neoplasms (Ovarian Cancer) 09/2011
1	Ovarian Epithelial Carcinoma 09/2011
1	Fibrosis (Cirrhosis) 08/2011
1	Liver Neoplasms (Liver Cancer) 11/2010
1	Intellectual Disability (Idiocy) 08/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2009
1	Acute Erythroblastic Leukemia (Erythroleukemia) 12/2009
1	Colonic Neoplasms (Colon Cancer) 08/2008
1	Hepatomegaly 04/2008
1	Hypertrophy 04/2008
1	Colorectal Neoplasms (Colorectal Cancer) 02/2008

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2002
8	Co-Repressor ProteinsIBA 03/2015 - 03/2003
7	ChromatinIBA 08/2020 - 04/2008
6	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2004
6	Histone Deacetylase InhibitorsIBA 11/2019 - 04/2008
5	Histone Deacetylases (Histone Deacetylase)IBA 02/2016 - 03/2003
4	EnzymesIBA 08/2020 - 12/2005
4	histone deacetylase 3IBA 11/2019 - 03/2011
4	Dextrans (Dextran)FDA Link 01/2019 - 08/2006
4	Histones (Histone)IBA 01/2017 - 12/2005
4	Messenger RNA (mRNA)IBA 10/2013 - 07/2002
3	AzoxymethaneIBA 01/2022 - 02/2011
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2019 - 08/2006
3	DNA (Deoxyribonucleic Acid)IBA 09/2011 - 05/2004
2	RNA (Ribonucleic Acid)IBA 08/2020 - 08/2017
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 03/2003 - 07/2002
1	Dextran SulfateIBA 01/2022
1	venetoclaxIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020
1	human ERBB2 proteinIBA 11/2020
1	Lysine (L-Lysine)FDA Link 08/2020
1	CytokinesIBA 01/2019
1	Flavin-Adenine Dinucleotide (FAD)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	NAD (NADH)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 02/2016
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2016
1	CholesterolIBA 01/2016
1	romidepsin (FK228)FDA Link 07/2015
1	Vorinostat FDA Link 07/2015
1	SodiumIBA 10/2013
1	Oncogene Proteins (Oncogene Protein)IBA 07/2013
1	DepsipeptidesIBA 01/2013
1	Cisplatin (Platino)FDA LinkGeneric 09/2011
1	PlatinumIBA 09/2011
1	KetonesIBA 09/2011
1	Matrix Metalloproteinases (MMPs)IBA 08/2011
1	Small Interfering RNA (siRNA)IBA 11/2010
1	EpitopesIBA 12/2009
1	Basic Helix-Loop-Helix Transcription FactorsIBA 12/2009
1	Cyclin-Dependent Kinase Inhibitor p16IBA 08/2008
1	CarbohydratesIBA 04/2008
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 12/2005
1	Core Binding Factor beta SubunitIBA 12/2005
1	Retinoic Acid Receptor alphaIBA 04/2004
1	gamma Catenin (Plakoglobin)IBA 04/2004
1	UbiquitinIBA 03/2003
1	Repressor ProteinsIBA 11/2002

Therapy/Procedure

7	Therapeutics 11/2020 - 07/2003
1	Neoadjuvant Therapy 11/2020
1	Drug Therapy (Chemotherapy) 09/2011